GVBL logo

Genomic Valley Biotech Ltd

GVBL·BSE·
29.88 +0.00 (+0.00%)
Market Cap9.13 Cr
PE Ratio25.32
Volume100
Day High - Low29.88 - 29.88
52W High-Low41.95 - 20.10
DocStoX Score
3.1/10
Poor
Fair Value
Sign in to see
ROE
0.77%
Weak
P/E
25.32x
Fair
Debt / Equity
0.00
Low
Industry
Healthcare
Biotechnology
Overall View
Poor

Price performance

52W20.10
41.95
DocStoX take

Held back by growth (0.8).

DocStoX score

Low confidence
3.1
/10
Poor
Quality
Modest
ROE 0.8%
Valuation
Rich
P/E 25.3×
Growth
Flat
Revenue +5.2% 5Y CAGR
Risk
Moderate
D/E 0.00
Momentum
Soft
45% of 52-week range

At a glance

Market Cap
₹9 Cr
52W High / Low
₹42 / ₹20
Dividend Yield
0.00%
Promoter Holding
46.06%
EPS (TTM)
₹1.18
Book Value
₹12.85

Key highlights

  • Healthy net margin (43%)
  • Low leverage — D/E 0.00
  • Profit shrinking 64% a year
  • Growth is weak (0.8/10)
2 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Biotechnology

Genomic Valley Biotech Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.